Literature DB >> 21511350

Buffalopox outbreak in humans and animals in Western Maharashtra, India.

Yogesh K Gurav1, Chandrashekhar G Raut, Pragya D Yadav, Babasaheb V Tandale, Aruna Sivaram, Milind D Pore, Atanu Basu, Devendra T Mourya, Akhilesh C Mishra.   

Abstract

An outbreak of febrile illness with rash was reported in humans and buffaloes with pox lesions in some villages of Solapur and Kolhapur districts of Maharashtra state, India. Detailed clinico-epidemiological investigations were done with collection of blood, vesicular fluid and scab from humans and animals. A total of 166 suspected human cases from Kasegaon village in Solapur district and 185 cases were reported from 21 different villages from Kolhapur district. The attack rate in humans in Kasegaon village was 6.6% while in Kolhapur district the attack rate for buffaloes was 11.7%. Pox-like lesions were associated with fever, malaise, pain at site of lesion and axillary and inguinal lymphadenopathy in the humans. Infected buffaloes had lesions on teats, udders, external ears and eyelids. Laboratory investigations included detection of Buffalopox virus (BPXV) by electron microscopy (EM), virus isolation and polymerase chain reaction (PCR). Presence of BPXV was confirmed in 7 human cases and one buffalo in Kasegaon and 14 human cases from Kolhapur. The virus was isolated from 3 clinical specimens and Orthopoxvirus (OPXV) particles could be observed in EM. Thus, BPXV was identified as the etiological agent of the outbreak among both humans and buffaloes. Phylogenetic analysis based on the ATI and C18L gene revealed that a single strain of virus is circulating in India. Re-emergence of OPXV like BPXV is a real danger and contingency planning is needed to define prophylactic and therapeutic strategies to prevent or stop an epidemic. Considering the productivity losses caused by buffalopox infection and its zoonotic impact, the importance of control measures in reducing the economic and public health impact cannot be underestimated.
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21511350     DOI: 10.1016/j.prevetmed.2011.03.008

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  17 in total

Review 1.  The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data.

Authors:  M Shannon Keckler; Mary G Reynolds; Inger K Damon; Kevin L Karem
Journal:  Vaccine       Date:  2013-08-27       Impact factor: 3.641

2.  Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.

Authors:  Sophie Duraffour; Graciela Andrei; Dimitri Topalis; Marcela Krečmerová; Jean-Marc Crance; Daniel Garin; Robert Snoeck
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.

Authors:  Jitendra Kumar; Viveka Nand Yadav; Swastik Phulera; Ashish Kamble; Avneesh Kumar Gautam; Hemendra Singh Panwar; Arvind Sahu
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

4.  The Vaccinia Virus H3 Envelope Protein, a Major Target of Neutralizing Antibodies, Exhibits a Glycosyltransferase Fold and Binds UDP-Glucose.

Authors:  Kavita Singh; Apostolos G Gittis; Rossitza K Gitti; Stanley A Ostazeski; Hua-Poo Su; David N Garboczi
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

5.  Educational Approach to Prevent the Burden of Vaccinia Virus Infections in a Bovine Vaccinia Endemic Area in Brazil.

Authors:  Galileu Barbosa Costa; Jaqueline Silva de Oliveira; Michael B Townsend; William C Carson; Iara Apolinário Borges; Andrea M McCollum; Erna Geessien Kroon; Panayampalli Subbian Satheshkumar; Mary G Reynolds; Yoshinori J Nakazawa; Giliane de Souza Trindade
Journal:  Pathogens       Date:  2021-04-23

6.  Sequence and phylogenetic analysis of host-range (E3L, K3L, and C7L) and structural protein (B5R) genes of buffalopox virus isolates from buffalo, cattle, and human in India.

Authors:  Bidhan Ch Bera; K Shanmugasundaram; Sanjay Barua; Taruna Anand; T Riyesh; Rajesh K Vaid; Nitin Virmani; Manish Bansal; Brihaspati N Shukla; Praveen Malik; Raj K Singh
Journal:  Virus Genes       Date:  2012-08-08       Impact factor: 2.198

7.  Vaccinia virus Transmission through Experimentally Contaminated Milk Using a Murine Model.

Authors:  Izabelle Silva Rehfeld; Maria Isabel Maldonado Coelho Guedes; Ana Luiza Soares Fraiha; Aristóteles Gomes Costa; Ana Carolina Diniz Matos; Aparecida Tatiane Lino Fiúza; Zélia Inês Portela Lobato
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

8.  Laboratory-acquired buffalopox virus infection, India.

Authors:  Thachamvally Riyesh; Shanmugasundaram Karuppusamy; Bidhan C Bera; Sanjay Barua; Nitin Virmani; Sarita Yadav; Rajesh K Vaid; Taruna Anand; Manish Bansal; Praveen Malik; Inderjeet Pahuja; Raj K Singh
Journal:  Emerg Infect Dis       Date:  2014-02       Impact factor: 6.883

Review 9.  Vaccinia Virus Natural Infections in Brazil: The Good, the Bad, and the Ugly.

Authors:  Jaqueline Silva de Oliveira; Poliana de Oliveira Figueiredo; Galileu Barbosa Costa; Felipe Lopes de Assis; Betânia Paiva Drumond; Flávio Guimarães da Fonseca; Maurício Lacerda Nogueira; Erna Geessien Kroon; Giliane de Souza Trindade
Journal:  Viruses       Date:  2017-11-15       Impact factor: 5.048

Review 10.  Bovine Vaccinia: Insights into the Disease in Cattle.

Authors:  Ana Carolina Diniz Matos; Izabelle Silva Rehfeld; Maria Isabel Maldonado Coelho Guedes; Zélia Inês Portela Lobato
Journal:  Viruses       Date:  2018-03-09       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.